A prospective observational study on conversion surgery for esophageal cancer with distant metastasis
Not Applicable
Recruiting
- Conditions
- esophageal cancer
- Registration Number
- JPRN-UMIN000050229
- Lead Sponsor
- Kansai Rosai Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Active multiple cancers at the start of first treatment Previous history of anti-PD-1 antibody, anti-PD-L1 antibody, anti-PD-L2 antibody, anti-CD137 antibody, anti-CTLA-4 antibody, or other antibody therapy or drug therapy for the purpose of controlling T cells patients with History of autoimmune disease, interstitial pneumonia, history of organ transplantation, or tuberculosis Patients who are expected to undergo esophageal or tracheal stenting Patients who are judged to lack the ability to consent due to complications such as dementia Patients who are judged to be inappropriate for this study by the attending physician
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival (assessed by 3-year survival rate)
- Secondary Outcome Measures
Name Time Method Treatment content, progression-free survival, response rate, disease control rate, adverse events, safety of conversion surgery (intraoperative and postoperative complications), overall survival in R0 resection patients, progression-free survival, date of recurrence, recurrence form, pathological response